2m 2m 2m 2m 2m 2m 2m
10X GENOMICS-A (TXG)
NASDAQ
$47.44+$0.17 (+0.36%)
Price as of Aug 03, 2026 9:00 AM EDT- $5.5BMarket Cap
- 261.39%1-Year Change
- Health Information ServicesIndustry
10X GENOMICS-A (TXG)
$47.44+$0.17 (+0.36%)
TXG | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $47.27 | ||
Change | -$2.16 (-4.37%) | ||
Open | $49.86 | ||
High | $50.34 | ||
Low | $46.25 | ||
Previous Close | $49.43 | ||
Volume | 2,869,326 | ||
30-Day Average Volume | 2,889,041 | ||
1-Week Change | 2.16% | ||
1-Month Change | 23.29% | ||
1-Year Change | 261.39% | ||
3-Year Change | -24.94% | ||
5-Year Change | -74.20% | ||
Fundamentals | |||
Shares Outstanding | 116.9M | ||
Total Assets | $1.0B | ||
Market Cap | $5.5B | ||
Enterprise Value | $5.0B | ||
Period: QTR TTM FY | |||
Revenue | $149.9M | ||
Net Income | -$13.5M | ||
Free Cash Flow | $24.5M | ||
EBIT | -$12.8M | ||
EBITDA | -$2.9M | ||
Net Working Capital | $556.1M | ||
EPS | -$0.10 | ||
Enterprise Value/EBITDA | -1,742 | ||
Enterprise Value/Revenue | 34 | ||
P/B | 7 | ||
P/E | -473 | ||
PEG | -21 | ||
Price/Free Cash Flow | 225 | ||
Price/Operating Cash Flow | 212 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue